Redox-dependent internalization of the purinergic P2Y


Journal

Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400

Informations de publication

Date de publication:
11 01 2022
Historique:
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 1 4 2022
Statut: ppublish

Résumé

After ligand stimulation, many G protein–coupled receptors (GPCRs) undergo β-arrestin–dependent desensitization, during which they are internalized and either degraded or recycled to the plasma membrane. Some GPCRs are not subject to this type of desensitization because they lack the residues required to interact with β-arrestins. We identified a mechanism of redox-dependent alternative internalization (REDAI) that promotes the internalization and degradation of the purinergic P2Y

Identifiants

pubmed: 35015570
doi: 10.1126/scisignal.abj0644
doi:

Substances chimiques

Receptors, Purinergic P2 0
beta-Arrestins 0
purinoceptor P2Y6 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabj0644

Auteurs

Kazuhiro Nishiyama (K)

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

Akiyuki Nishimura (A)

National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences (NINS), Okazaki 444-8787, Japan.
Exploratory Research Center on Life and Living Systems (ExCELLS), NINS, Okazaki 444-8787, Japan.

Kakeru Shimoda (K)

National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences (NINS), Okazaki 444-8787, Japan.
Exploratory Research Center on Life and Living Systems (ExCELLS), NINS, Okazaki 444-8787, Japan.
Department of Physiological Sciences, SOKENDAI (School of Life Science, Graduate University for Advanced Studies), Okazaki 444-8787, Japan.

Tomohiro Tanaka (T)

National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences (NINS), Okazaki 444-8787, Japan.
Exploratory Research Center on Life and Living Systems (ExCELLS), NINS, Okazaki 444-8787, Japan.
Center for Novel Science Initiatives (CNSI), NINS, Tokyo 105-0001, Japan.

Yuri Kato (Y)

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

Takahiro Shibata (T)

Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Aichi 464-8601, Japan.

Hiroshi Tanaka (H)

Department of Chemical Science and Engineering, Tokyo Institute of Technology, 2-12-1-H-101, Ookayama, Meguro, Tokyo 152-8552, Japan.

Hitoshi Kurose (H)

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

Yasu-Taka Azuma (YT)

Division of Veterinary Science, Osaka Prefecture University Graduate School of Life and Environmental Science, Osaka 598-8531, Japan.

Hideshi Ihara (H)

Department of Biological Sciences, Graduate School of Science, Osaka Prefecture University, Osaka 599-8531, Japan.

Yoshito Kumagai (Y)

Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.

Takaaki Akaike (T)

Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan.

Philip Eaton (P)

William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.

Koji Uchida (K)

Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo 113-8657, Japan.

Motohiro Nishida (M)

Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences (NINS), Okazaki 444-8787, Japan.
Exploratory Research Center on Life and Living Systems (ExCELLS), NINS, Okazaki 444-8787, Japan.
Department of Physiological Sciences, SOKENDAI (School of Life Science, Graduate University for Advanced Studies), Okazaki 444-8787, Japan.
Center for Novel Science Initiatives (CNSI), NINS, Tokyo 105-0001, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH